North America Leads the Apheresis Boom: Market to Hit USD 1.7B by 2029

 Market Overview

Apheresis is a medical procedure in which blood is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is used therapeutically to remove harmful substances from the blood or to collect specific blood components for transfusion or further processing. The North American apheresis market encompasses the sales of apheresis devices, disposables, and related services within the United States, Canada, and Mexico.

Market Size and Growth

The North American apheresis market is substantial and is characterized by consistent growth. The market size is currently significant, and projections indicate a robust expansion over the forecast period.

Key Statistics:

• Projected Market Size by 2029: USD 1.7 billion
• Compound Annual Growth Rate (CAGR): 8.4% (2024-2029)

Download PDF Brochure

This growth is driven by a confluence of factors, including:

• Increasing Prevalence of Target Diseases: The rising incidence of autoimmune disorders, hematological malignancies, and other conditions treatable with apheresis is fueling demand.
• Technological Advancements: Innovations in apheresis devices and techniques are improving treatment efficacy and expanding the range of applications.
• Growing Adoption of Apheresis Procedures: Healthcare professionals are increasingly recognizing the benefits of apheresis in various therapeutic areas.
• Rising Healthcare Expenditure: Increased healthcare spending in North America is supporting the adoption of advanced medical technologies like apheresis.

Market Drivers

Several key drivers are propelling the growth of the apheresis market in North America:

1. Rising Incidence of Autoimmune Diseases: Autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis, are becoming more prevalent. Apheresis is used to manage these conditions by removing autoantibodies and immune complexes from the blood.
2. Advancements in Apheresis Technology: Continuous improvements in apheresis devices, including enhanced selectivity, efficiency, and safety, are driving market growth. New technologies are also expanding the applications of apheresis.
3. Increasing Demand for Therapeutic Apheresis: Therapeutic apheresis is gaining traction as a treatment option for various conditions, including neurological disorders, renal diseases, and hematological disorders.
4. Growing Awareness and Acceptance of Apheresis: Increased awareness among healthcare professionals and patients about the benefits of apheresis is contributing to its wider adoption.
5. Expanding Applications in Stem Cell Transplantation: Apheresis is crucial in stem cell collection for autologous and allogeneic stem cell transplantation, which is increasingly used in the treatment of hematological malignancies and other diseases.
6. Favorable Reimbursement Policies: Supportive reimbursement policies for apheresis procedures in North America are encouraging its use.

Market Segmentation

The North American apheresis market can be segmented based on several factors:

• By Product Type:
• Devices: Apheresis machines, centrifuges, and other equipment.
• Disposables: Tubing sets, collection bags, and other single-use items.
• By Application:
• Therapeutic Apheresis: Treatment of autoimmune diseases, neurological disorders, renal diseases, and hematological disorders.
• Collection Apheresis: Collection of platelets, plasma, and stem cells for transfusion or further processing.
• By End-User:
• Hospitals
• Blood Centers
• Apheresis Centers
• Research Institutes

Competitive Landscape

The North American apheresis market is characterized by the presence of several key players, including established medical device companies and specialized apheresis product manufacturers. Key companies operating in the market include:

• Terumo BCT
• Haemonetics Corporation
• Fresenius Medical Care
• Asahi Kasei Medical
• Kaneka Corporation

These companies compete on the basis of product innovation, quality, service, and price. Strategic collaborations, acquisitions, and partnerships are common strategies employed by these players to strengthen their market position.

Regional Analysis

The North American apheresis market is dominated by the United States, followed by Canada and Mexico. The United States accounts for the largest share of the market due to its advanced healthcare infrastructure, high healthcare expenditure, and large patient population. Canada is also a significant market, driven by its universal healthcare system and increasing adoption of apheresis procedures. Mexico represents a smaller but growing market, with increasing healthcare access and rising awareness of apheresis.

Challenges and Opportunities

While the North American apheresis market offers significant growth opportunities, it also faces certain challenges:

Challenges:

• High Cost of Apheresis Procedures: The cost of apheresis devices and disposables can be a barrier to adoption, particularly in resource-constrained settings.
• Lack of Trained Professionals: The need for skilled healthcare professionals to perform apheresis procedures can limit its availability.
• Regulatory Hurdles: Stringent regulatory requirements for medical devices can delay the introduction of new apheresis technologies.

Opportunities:

• Expanding Applications of Apheresis: Research and development efforts are expanding the applications of apheresis in new therapeutic areas, such as cancer immunotherapy and regenerative medicine.
• Development of More Efficient and Selective Apheresis Devices: Innovations in apheresis technology are leading to the development of more efficient and selective devices, improving treatment outcomes and reducing side effects.
• Increasing Focus on Personalized Medicine: Apheresis can be tailored to individual patient needs, aligning with the growing trend of personalized medicine.
• Growth in Emerging Markets: Expanding healthcare infrastructure and increasing healthcare expenditure in emerging markets within North America, such as certain regions in Mexico, present growth opportunities for apheresis product manufacturers.

Future Trends

The North American apheresis market is expected to witness several key trends in the coming years:

• Adoption of Automated Apheresis Systems: Automated apheresis systems are becoming increasingly popular due to their ease of use, reduced operator error, and improved efficiency.
• Integration of Apheresis with Other Therapies: Apheresis is being increasingly integrated with other therapies, such as chemotherapy and immunotherapy, to enhance treatment outcomes.
• Development of Point-of-Care Apheresis Devices: Point-of-care apheresis devices are being developed to enable rapid and convenient apheresis procedures in various settings, such as emergency rooms and outpatient clinics.
• Focus on Patient-Centric Care: Healthcare providers are increasingly focusing on patient-centric care, tailoring apheresis procedures to individual patient needs and preferences.

Conclusion

The North American apheresis market is poised for continued growth in the coming years, driven by increasing prevalence of target diseases, technological advancements, and growing adoption of apheresis procedures. While challenges such as high costs and lack of trained professionals exist, the market offers significant opportunities for growth and innovation. Key players in the market are focusing on product development, strategic collaborations, and market expansion to capitalize on these opportunities. The future of the North American apheresis market looks promising, with the potential to improve patient outcomes and transform the treatment of various diseases.